0 0

Challenges and Opportunities in the Manufacturing of New Treatment Modalities

Jun 1, 2020 8:00am ‐ Jun 1, 2020 9:30am

Credits: None available.

Speaker(s):

Wilson W. Bryan, M.D., Director, Office of Tissues and Advanced Therapies, CBER/FDA
Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration, Genentech, A Member of the Roche Group
Eric Felz, Associate Director Validation, Takeda Pharmaceutical Company
Tim Howard, PE, CPIP, Interim CEO & President, ISPE
Carol Lynch, President, Head-North America, Sandoz US

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.